Loading data
IMUXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 81.98 m USD | 80.05 m USD | 83.22 m USD | 71.26 m USD | 61.12 m USD |
| Operating profit | -103.23 m USD | -98.05 m USD | -99.22 m USD | -119.49 m USD | -91.67 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -97.17 m USD | -100.51 m USD | -93.61 m USD | -120.41 m USD | -92.95 m USD |
| Basic earnings per share | -0.62 USD/share | -1 USD/share | -2.11 USD/share | -3.78 USD/share | -3.93 USD/share |
| Diluted earnings per share | -0.62 USD/share | -1 USD/share | -2.11 USD/share | -3.78 USD/share | -3.93 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.